High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: A single centre retrospective cohort study
- Guiliana Mas-Ubillus,
- Pedro J. Ortiz(corresponding author),
- ,
- Paola Sarzo-Miranda,
- Patricia Muñoz-Aguirre,
- Alejandra Diaz-Ramos
- Universidad Peruana Cayetano Heredia,
- Hospital Nacional Arzobispo Loayza,
Open access
Publication Information
Output type
Original language
EnglishArticle number
e0265089Journal (Volume, Issue Number)
PLoS ONE (Volume 17, Issue 3 March 2022)Publication milestones
- Published - 03/2022
Publication status
Publication IDs
- Scopus: 85126076011
- PubMed: 35259196
Abstract
Background Peru is the country with the world's highest COVID-19 death rate per capita. Characteristics associated with increased mortality among adult patients with COVID-19 pneumonia in this setting are not well described. Methods Retrospective, single-center cohort study including 1537 adult patients hospitalized with a diagnosis of SARS-CoV-2 pneumonia between May 2020 and August 2020 at a national hospital in Lima, Peru. The primary outcome measure was in-hospital mortality. Results In-hospital mortality was 49.71%. The mean age was 60 ± 14.25 years, and 68.38% were males. We found an association between mortality and inflammatory markers, mainly leukocytes, D-dimer, lactate dehydrogenase, C-reactive protein and ferritin. A multivariate model adjusted for age, hypertension, diabetes mellitus, and corticosteroid use demonstrated that in-hospital mortality was associated with greater age (RR: 2.01, 95%CI: 1.59-2.52) and a higher level of oxygen requirement (RR: 2.77, 95%CI: 2.13-3.62). Conclusions: In-hospital mortality among COVID-19 patients in Peru is high and is associated with greater age and higher oxygen requirements.
Funding Details
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
